• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FT4, FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FT4, FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 06437281190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/02/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The customer questioned elecsys ft4 ii assay (ft4 ii) and elecsys ft3 iii (ft3 iii) results from 1 patient tested on a cobas 8000 e 602 module.The customer provided the patient sample for investigation.Of the data provided, erroneous ft4 ii and ft3 iii results were identified between the customer's e602 module, a centaur analyzer, an e602 module used at the investigation site and a cobas e 411 immunoassay analyzer used at the investigation site.The erroneous results at the customer site were not reported outside of the laboratory.This medwatch will cover ft4 ii.Refer to medwatch with (b)(6) for information on the ft3 iii erroneous results.Refer to the attached data for patient results.There was no allegation that an adverse event occurred.The customer¿s e602 module serial number was (b)(4).The e602 module serial number used at the investigation site was (b)(4).The e411 analyzer serial number was (b)(4).The ft4 ii reagent lot number used at the investigation site was 246825 with an expiration date of jun-2018.
 
Manufacturer Narrative
The patient sample was investigated further where both the customer's ft3 iii and ft4 ii results and the ft3 iii and ft4 ii investigation results were reproduced.A streptavidin interference was not identified in the sample; however, considering the differing results between the different types of analyzers, the sample may contain an immunoglobulin that reacts with the ft3 iii and ft4 ii reagents which affects the sample results.The variance in the ft4 results many have been due to the interference factor not evenly distributed in the sample of may have been affected by the multiple freeze/thaw cycles.Product labeling states "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FT4, FREE THYROXINE
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6996422
MDR Text Key91930435
Report Number1823260-2017-02509
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K961489
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 12/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06437281190
Device Lot Number246825
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/16/2017
Initial Date FDA Received11/02/2017
Supplement Dates Manufacturer Received10/16/2017
Supplement Dates FDA Received12/06/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age70 YR
-
-